Exelon entered into an Equity Distribution Agreement with the Sales Agents on May 2, 2025, establishing an at-the-market program under which it may offer and sell shares of common stock from time to time with an aggregate gross sales price of up to $2,500,000,000.

1. 01

   Exelon entered into an Equity Distribution Agreement with the Sales Agents on May 2, 2025, establishing an at-the-market program under which it may offer and sell shares of common stock from time to time with an aggregate gross sales price of up to $2,500,000,000.

2. 02

   The company said it may enter into Forward Sale Agreements with the Forward Purchasers. It expects to receive no proceeds when the borrowed shares are sold, and to receive aggregate net cash proceeds equal to the number of shares multiplied by the forward sale price upon physical settlement.

3. 03

   The company said it has no obligation to issue or sell shares under the agreement and may suspend or terminate offers and sales at any time. It also said that if it cash settles or net share settles a Forward Sale Agreement, it may not receive proceeds and may owe cash or shares to the Forward Purchaser.

4. 04

   The company said it expects to use the net proceeds for general corporate purposes, including repayment of debt. It also explained that shares may be sold through at-the-market offerings, including on or through Nasdaq, or in privately negotiated transactions agreed to in writing.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.